Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
03/16/20174:30PMGlobeNewswire Inc.OpGen Announces Date of 2016 Fourth Quarter and Year End Financial Results Conference CallNASDAQ:OPGNOpGen Inc
03/01/20178:00AMGlobeNewswire Inc.OpGen to Present at the Cowen and Company 37th Annual Health Care ConferenceNASDAQ:OPGNOpGen Inc
02/27/20175:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
02/27/20175:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
02/14/201712:00PMGlobeNewswire Inc.OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology MeetingNASDAQ:OPGNOpGen Inc
02/10/20173:43PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:OPGNOpGen Inc
01/26/20175:38PMGlobeNewswire Inc.OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:OPGNOpGen Inc
01/26/20174:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
01/10/20173:03PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPGNOpGen Inc
12/19/20163:30PMGlobeNewswire Inc.OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial InfectionsNASDAQ:OPGNOpGen Inc
12/16/20164:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
12/16/20169:26AMGlobeNewswire Inc.OpGen Provides ATM Program UpdateNASDAQ:OPGNOpGen Inc
11/16/201610:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/14/20167:00AMGlobeNewswire Inc.OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic ResistanceNASDAQ:OPGNOpGen Inc
11/14/20166:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
10/27/20164:25PMGlobeNewswire Inc.Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant OrganismsNASDAQ:OPGNOpGen Inc
10/26/20168:00AMGlobeNewswire Inc.OpGenā€™s Infectious Disease Portfolio Highlighted at IDWeek 2016NASDAQ:OPGNOpGen Inc
10/24/20164:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/24/20164:01PMGlobeNewswire Inc.OpGen Reports 2016 Third Quarter Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
10/20/20169:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/19/20165:10PMGlobeNewswire Inc.OpGen Announces Date of Third Quarter 2016 Financial Results Conference CallNASDAQ:OPGNOpGen Inc
09/14/20165:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
09/13/20164:39PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPGNOpGen Inc
09/12/20166:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPGNOpGen Inc
09/09/20164:37PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPGNOpGen Inc
09/08/20167:30AMGlobeNewswire Inc.OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance CongressNASDAQ:OPGNOpGen Inc
09/07/20167:30AMGlobeNewswire Inc.OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment ConferenceNASDAQ:OPGNOpGen Inc
09/02/20164:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
08/31/20165:13PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPGNOpGen Inc
08/26/20165:30PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN